Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The two companies will continue combining components to make patient monitoring systems, under the new terms of the expanded deal that includes a "pledge program" to improve quality.
Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.
The U.S. is one of 23 countries that consider workforce AI training and education only a medium priority. Indeed, our homeland has a less detailed plan than 13 other nations.
The legal case brought by all 50 states, Washington D.C., and multiple U.S. territories against Purdue Pharma and the Sackler family has come to an end, with settlement funds set to be used for addiction recovery.
A class-action lawsuit claims CVS Health sent text messages to customers and patients, inciting fear over a PBM regulation up for vote in Louisiana. Plaintiffs allege the incident violates state data privacy and political communication laws.
The FDA has given its thumbs-up to software that calculates breast fibroglandular tissue volume (FGV) and the ratio of FGV to total breast volume on ultrasound imaging.
Notwithstanding CMS’ most-shoppable-services rule, radiology researchers find much work lies ahead “if the goal of online price estimators is for patients to use them.”
Suggesting the move will significantly advance radiology’s specialtywide imperative to “ditch the disk,” Montreal-based Intelerad Medical Systems has announced it is acquiring a longtime competitor in the image-exchange space.
Orthopedic cone-beam CT supplier CurveBeam AI has received the FDA’s breakthrough device designation for software that computes risk of fracture in patients with osteopenia.